DNA Sequence Dependent Monomer-Dimer Binding Modulation of Asymmetric Benzimidazole Derivatives

Journal of the American Chemical Society

Volumn 126, Issue 1, 2004, Pages 143-153

  Tanious, Farial A ^a   Hamelberg, Donald ^a   Bailly, Christian ^b   Czarny, Agnieska ^a   Boykin, David W ^a   Wilson, W David ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSENSORS; DERIVATIVES; DIMERS; MONOMERS; SPECTROSCOPIC ANALYSIS; SURFACE PLASMON RESONANCE;

MINOR GROOVE AGENTS;

DNA;

4 [5 (4 METHYL 1 PIPERAZINYL)(2,5' BI 1H BENZIMIDAZOL) 2' YL]PHENOL; ADENINE; AMIDINE; BENZIMIDAZOLE DERIVATIVE; DB 183; DB 185; DB 210; DIAMIDINE DERIVATIVE; DIMER; DNA FRAGMENT; MONOMER; PIBENZIMOL; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOSENSOR; CIRCULAR DICHROISM; DNA BINDING; DNA DRUG COMPLEX; DNA FOOTPRINTING; DNA RECOGNITION MOTIF; DNA SEQUENCE; DNA STRAND; DNA STRUCTURE; GENE TARGETING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PROTEIN INTERACTION; PROTEIN MOTIF; RECEPTOR BINDING; SURFACE PLASMON RESONANCE;

EID: 0347720652     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja030403+     Document Type: Article

References (96)

1. (a) Tidwell, R. R.; Boykin, W. D. In DNA and RNA Binders: from Small Molecules to Drugs; Demeunynck, M., Bailly, C., Wilson, W. D., Eds.; Wiley-VCH: 2003: Vol. 2, Chapter 16, pp 414-460.
2. (b) Boykin, D. W.; Kumar, A.; Spychala, J.; Zhou, M.; Lombardi, R. L.; Wilson, W. D.; Dykstra, C. C.; Jones, S. K.; Hall, J. E.; Tidwell, R. R.; Laughton, C.; Nunn, C. M.; Neidle, S. J. Med. Chem. 1995, 38, 912-916.
3. (c) Edwards, K. J.; Jenkins, T. C.; Neidle, S. Biochemistry 1992, 31, 7104-7109.
4. (d) Nunn, C. M.; Jenkins. T. C.; Neidle. S. Biochemistry 1993, 32, 13 838-13 845.
5. (a) Lansiaux, A.; Dassonnville. L.; Facompre, M.; Kumar, A.; Stephens. C. E.; Bajic, M.; Tanious. A.; Wilson, W. D.; Boykin, D. W.; Bailly, C. J. Med. Chem. 2002, 45, 1994-2002.
6. (b) Lansiaux, A.; Tanious, F.; Mishal, Z.; Dassonneville. L.; Kumar, A.; Stephens, C. E.; Hu, Q.; Wilson, W. D.; Boykin, D. W.; Bailly, C. Cancer Res. 2002, 62, 7219-7229.
7. (a) Czarny, A.; Boykin, D. W.; Wood, A. A.; Nunn, C. M.; Neidle, S.; Zhao, M.; Wilson, W. D. J. Am. Chem. Soc. 1995, 117, 4716-4717.
8. (b) Clark. G. R.; Boykin, D. W.; Czarny, A.; Neidle, S. Nucleic Acids Res. 1997, 25, 1510-1515.
9. (c)Wang, L.; Bailly, C.; Kumar, A.; Ding, D.; Bajic, M.; Boykin, D. W.; Wilson. W. D. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 12-16.
10. (d) Wang, L.; Carrasco. C.; Kumar. A.; Stephens. C. E.; Bailly, C.; Boykin, D. W.; Wilson. W. D. Biochemistry 2001, 40, 2511-2521.
11. (e) Bailly, C.; Tardy, C.; Wang, L.; Armitage, B.; Hopkins, K.; Kumar. A.; Schuster. G. B.; Boykin, D. W.; Wilson. W. D. Biochemistry 2001, 40, 9770-9779.
12. (f) Tanious, F.; Wilson, W. D.; Wang, Lei.; Kumar, A.; Boykin, D. W.; Marty, C.; Baldeyrou, B.; Bailly, C. Biochemistry (2003).
13. (a) Abu-Daya, A.; Brown, P. M.; Fox, K. R. Nucleic Acids Res. 1995, 23, 3385-3392.
14. (b) Abu-Daya, A.; Fox, K. R. Nucleic Acids Res. 1997, 25, 4962-4969.
15. (c) Bailly, C. In DNA and RNA Binders: from Small Molecules to Drugs; Demeunynck, M., Bailly, C., Wilson, W. D., Eds.; Wiley-VCH: 2003; Vol. 2, Chapter 20, pp 538-575.
16. (d) Bailly, C.; Chessari, G.; Carrasco, C.; Joubert, A.; Mann, J.; Wilson, W. D.; Neidle, S. Nucleic Acids Res. 2003, 31, 1514-1524.
17. (e) Breusegem, S. Y.; Sadat-Ebrahimi, S. E.; Douglas, K. T.; Bichenkova, E. V.; Clegg, R. M.; Loontiens, F. G. J. Med. Chem. 2001, 44, 2503-2506.
18. (f) Bostock-Smith, C. E.; Harris, S. A.; Laughton, C. A.; Searle, M. S. Nucleic Acids Res. 2001, 29, 693-702.
19. (g) Carrondo, M. A. A. de C. T.; Coll, M.; Aymami, J.; Wang, A. H. J.; Van der Marel, G. A.; Van Boom, J. H.; Rich, A. Biochemistry 1989, 28, 7849-7859.
20. (h) Haq, I.; Ladbury, J. E.; Chowdhry, B. Z.; Jenkins, T. C.; Chaires, J. B. J. Mol. Biol. 1997, 271, 244-257.
21. (i) Satz, A. L.; Bruice, T. C. Acc. Chem. Res. 2002, 35, 86-95.
22. (j) Satz, A. L.; White, C. M.; Beerman, T. A.; Bruice, T. C. Biochemistry 2001, 40, 6465-6474.
23. (k) Satz, A. L.; Bruice, T. C. J. Am. Chem. Soc. 2001, 123, 2469-2477.
24. (l) Teng, M.-K.; Usman, N.; Frederick, C. A.; Wang, A. H.-J. Nucleic Acids Res. 1988, 16, 2671-2690.
25. (m) Loontiens, F. G.; Regenfuss, P.; Zechel, A.; Dumortier, L.; Clegg, R. M. Biochemistry 1990, 29, 9029-9039.
26. (n) Wood, A. A.; Nunn, C. M.; Czarny, A.; Boykin, D. W.; Neidle, S. Nucleic Acids Res. 1995, 23, 3678-3684.
27. (o) Rosu, F.; Gabelica, V.; Houssier, C.; Pauw, E. D. Nucleic Acids Res. 2002, 30, e82.
28. (p) Ebrahimi, S. E.; Bibby, M. C.; Fox, K. R.; Douglas, K. T. Anticancer Drug Des. 1995, 10, 463-479.
29. (a) Mazur, S.; Tanious, F. A.; Ding, D.; Kumar, A.; Boykin, D. W.; Simpson, I. J.; Neidle, S.; Wilson, W. D. J. Mol. Biol. 2000, 300, 321-337.
30. (b) Trent, J. O.; Clark, G. R.; Kumar, A.; Wilson, W. D.; Boykin, D. W.; Hall, J. E.; Tidwell, R. R.; Blagburn, B. L.; Neidle, S. J. Med. Chem. 1996, 39, 4554-4562.
31. (a) Wemmer, D. E. Annu. Rev. Biophys. Biomol. Struct. 2000, 29, 439-461.
32. (b) Dervan, P. B. Bioorg. Med. Chem. 2001, 9, 2215 -2235.
33. Pelton, J. G.; Wemmer, D. E. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5723-5727.
34. (a) Moravek, Z.; Neidle, S.; Schneider, B. Nucleic Acids Res. 2002, 30, 1182-1191.
35. (b) Bailly, C. In Advances in DNA Sequence Specific Agents; Palumbo, M., Ed; JAI Press Inc.: London, 1988; Vol. 3 pp 97-156.
36. (c) Chaires, J. B. Curr. Opin. Struct. Biol. 1998, 8, 314-320.
37. (d) Sondhi, S. M.; Reddy, B.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313-358.
38. (e) Kopka, M. L.; Larsen, T. A. In Nucleic Acid Targeted Drug Design; Propst, C. L., Perun, T. J., Eds.; Marcel Dekker Inc.: New York, 1992; pp 303-374.
39. (a) Drobyshev, A. L.; Zasedatelev, A. S.; Yershov, G. M.; Mirzabekov, A. D. Nucleic Acids Res. 1999, 27, 4100-4105.
40. (b) Fede, A.; Billeter, M.; Leupin, W.; Wüthrich, K. Structure 1993, 1, 177-186.
41. (c) Parkinson, J. A.; Barber, J.; Douglas, K. T.; Rosamond, J.; Sharples, D. Biochemistry 1990, 29, 10 181-10 190.
42. (d) Pjura, P. E.; Grzeskoniak, K.; Dickerson, R. E. J. Mol. Biol. 1987, 197, 257-271.
43. (e) Quintana, J. R.; Lipanov, A. A.; Dickerson, R. E. Biochemistry 1991, 30, 10 294-10 306.
44. (f) Spink, N.; Brown, D. G.; Skelly, J. V.; Neidle, S. Nucleic Acids Res. 1994, 22, 1607-1612.
45. (g) Sriram, M.; van der Marel, G. A.; Roelen, H. L. P. F.; van Boom, J. H.; Wang, A. H.-J. EMBO J. 1992, 11, 225-232.
46. (h) Vega, M. C.; Garcia Saez, I.; Aymami, J.; Eritja, R.; Van der Marel, G. A.; van Boom, J. H.; Rich, A.; Coll, M. Eur. J. Biochem. 1994, 222, 721-726.
47. (i) Breusegem, S. Y.; Clegg, R. M.; Loontiens, F. G. J. Mol. Biol. 2002, 315, 1049-1061.
48. (a) Baily, C.; Chaires, J. B. Bioconjugate Chem. 1998, 9, 513-538.
49. (b) Kim, J. S.; Gatto, B.; Yu, C.; Liu, A.; Liu, L. F.; LaVoie, E. J. Med. Chem. 1996, 39, 992-998.
50. (c) Lombardi, R. L.; Tanious, F. A.; Ramachandran, K.; Tidwell, R. R.; Wilson, W. D. J. Med. Chem. 1996, 39, 1452-1462.
51. (d) Minehan, T. G.; Gottwald, K.; Dervan, P. B. Helv. Chim. Acta 2000, 83, 2197-2213.
52. (e) Wang, H.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Design 1994, 9, 153-180.
53. (a) Joubert, A.; Sun, X.-W.; Johansson, E.; Bailly, C.; Mann, J.; Neidle, S. Biochemistry 2003, 42, 5984-5992.
54. (b) Mann, J.; Baron, A.; Opoku-Boahen, Y.; Johansson, E.; Parkinson, G.; Kelland, L. R.; Neidle, S. J. Med. Chem. 2001, 44, 138-144.
55. (a) Aymami, J.; Nunn, C. M.; Neidle, S. Nucleic Acids Res. 1999, 27, 2691-2698.
56. (b) Goldman, G. H.; Yu, C.; Wu, H.-Y.; Sanders, M. M.; La Voie, E. J.; Liu, L. F. Biochemistry 1997, 36, 6488-6494.
57. (c) Ji, Y. H.; Bur, D.; Hasler, W.; Bailly, C.; Waring, M. J.; Hochstrasser, R.; Leupin, W. BioOrg. Med. Chem. 2001, 9, 2905-2919.
58. (d) Kim, J. S.; Sun, Q.; Yu, C.; Liu, A.; Liu, L. F.; LaVoie, E. Bioorg. Med. Chem. 1998, 6, 163-172.
59. (e) Pilch, D. S.; Xu, Z.; Sun, Q.; LaVoie, E.; Liu, L. F.; Breslauer, K. J. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 13 565-13 570.
60. (f) Pilch, D. S.; Xu, Z.; Sun, Q.; LaVoie, E. J.; Liu, L. F.; Geacintov, N. E.; Breslauer, K. J. Drug. Des. Discovery 1996, 13, 115-133.
61. (g) Xu, Z.; Li, T.-K.; Kim, J. S.; LaVoie, E.; Breslauer, K. J.; Liu. L. F.; Pilch, D. S. Biochemistry 1998, 37, 3558-3566.
62. Price, M. A.; Tullius, T. D. Biochemistry 1993, 32, 127-136.
63. (a) Lavesa, M.; Fox, K. R. Anal. Biochem. 2001, 293, 246-250.
64. (b) Bailly, C.; Waring, M. J. J. Biomol. Struct. Dyn. 1995, 12, 869-898.
65. Czarny, A.; Wilson, W. D.; Boykin, D. W. J. Heterocyclic Chem. 1996. 33, 1393-1397.
66. Fasman, G. D. In Handbook of Biochemistrv and Molecular Biology: Nucleic Acids; CRC Press: Cleveland, OH, 1975; Vol. 1 p 589.
67. Davis, T. M.; Wilson, W. D. Anal. Biochem. 2000, 284, 348-353.
68. Case, D. A.; Pearlman, D. A.; Caldwell, J. W.; Cheatham, T. E., III, Ross, W. S.; Simmerling, C. L.; Darden, T. A.; Merz, K. M.; Stanton, R. V.; Cheng, A. L.; Vincent, J. J.; Crowley, M.; Ferguson, D. M.; Radmer, R. J.; Seibel, G. L.; Singh, U. C.; Weiner. P. K. and Kollman, P. A. 1997. 5.1 Edition; University of California, San Francisco.
69. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. J. Chem. Phys. 1983, 79, 926-935.
70. Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Jr., K. M. M.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. J. Am. Chem. Soc. 1995, 117, 5179-5197.
71. Bayly, C. I.; Cieplak, P.; Cornell, W. D.; Kollman, P. A. J. Phys. Chem. 1993, 97, 10 269-10 280.
72. (a) Hamelberg, D.; McFail-Isom, L.; Williams, L. D.; Wilson, W. D. J. Am. Chem. Soc. 2000, 122, 10 513-10 520.
73. (b) Hamelberg, D.; Williams. L. D.; Wilson, W. D. J. Am. Chem. Soc. 2001, 123, 7745-7755.
74. Berendsen, H. J. C.; van Gunsteren, W. F.; Postma, J. P. M.; A. D. J. Chem. Phys. 1984, 81, 3684-3690.
75. Ryckaert, J. P.; Ciccotti, G.; Berendsen, H. J. C. J. Comput. Phys. 1977, 23, 327-341.
76. (a) Rocchia, W.; Alexov, E.; Honig, B. J. Phys. Chem. B. 2001, 105(28), 6507-6514.
77. (b) Nicholls, A.; Honig, B. J. Comput. Chem. 1991, 12, 435-445.
78. Sitkoff, D.; Sharp, K. A.; Honig, B. J. Phys. Chem. 1994, 98(7), 1978-1988.
79. Sanner, M.; Olson, A. J.; Spehner, J. C. Biopolymers 1996, 38(3), 305-320.
80. Weston, S. A.; Lahm, A.; Suck, D. J. Mol. Biol. 1992, 226, 1237-1256.
81. Nielsen, P. E.; Møllegaard, N. E.; Jeppesen, C. Nucleic Acids Res. 1990, 18, 3847-3851.
82. Nguyen, B.; Tardy, C.; Bailly, C.; Colson, P.; Houssier, C.; Kumar, A.; Boykin, D. W.; Wilson, W. D. Biopolymers 2002, 63, 281-297.
83. (a) Lyng, R.; Rodger, A.; Norden, B. Biopolymers 1992, 32, 1201-1214.
84. (b) Rodger, A.; Norden, B. Circular Dichroism and Linear Dichroism; Oxford University Press: New York, 1997.
85. Hurley, L. H. J. Med. Chem. 1989, 32, 2027-2033.
86. Hurley, L. H. Nat. Rev. Cancer 2002, 2, 188-200.
87. Liepinsh, E.; Leupin, W.; Otting, G. Nucleic Acids Res. 1994, 22, 2249-2254.
88. (a) Berman, H. M.; Schneider, B. In Oxford Handbook of Nucleic Acid Structure; Neidle. S., Ed.; Oxford University Press: New York, 1999, Chapter 9, 295-312.
89. (b) Crothers, D. M.; Shakked, Z. In Oxford Handbook of Nucleic Acid Structure; Neidle. S., Ed.; Oxford University Press: New York, 1999, chapter 14, 455-470.
90. (c) Balendiran, K.; Sundaralingam, J Biomol Struct Dyn. 1991, 9, 511-516.
91. Tereshko, V.; Urpi, L.; Malinina, L.; Huynh-Dinh, T.; Subirana, J. A. Biochemistry 1996, 35, 11 589-11 595.
92. Laughton, C.; Luisi, B. J Mol Biol. 1999, 288, 953-963.
93. (a) Bareket-Samish, A.; Cohen, I.; Haran, T. E. J. Mol. Biol. 2000, 299, 965-977.
94. (b) Moravek, Z.;, Neidle, S.; Schneider, B. Nucleic Acids Res. 2002, 30, 1182-1191.
95. Qian, X.; Strahs, D.; Schlick, T. J. Mol. Biol. 2001, 308, 681-703.
96. Umezawa, Y.; Nishio, M. Bioorg. Med. Chem. 2000, 8, 2643-2650.